ID   ACADV_HUMAN             Reviewed;         655 AA.
AC   P49748; B4DEB6; F5H2A9; O76056; Q8WUL0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 179.
DE   RecName: Full=Very long-chain specific acyl-CoA dehydrogenase, mitochondrial;
DE            Short=VLCAD;
DE            EC=1.3.8.9;
DE   Flags: Precursor;
GN   Name=ACADVL; Synonyms=VLCAD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7668252;
RA   Aoyama T., Souri M., Ueno I., Kamijo T., Yamaguchi S., Rhead W.J.,
RA   Tanaka K., Hashimoto T.;
RT   "Cloning of human very-long-chain acyl-coenzyme A dehydrogenase and
RT   molecular characterization of its deficiency in two patients.";
RL   Am. J. Hum. Genet. 57:273-283(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANTS.
RC   TISSUE=Placenta;
RX   PubMed=8845838; DOI=10.1093/hmg/5.4.461;
RA   Andresen B.S., Bross P., Vianey-Saban C., Divry P., Zabot M.-T.,
RA   Roe C.R., Nada M.A., Byskov A., Kruse T.A., Neve S., Kristiansen K.,
RA   Knudsen I., Corydon M.J., Gregersen N.;
RT   "Cloning and characterization of human very-long-chain acyl-CoA
RT   dehydrogenase cDNA, chromosomal assignment of the gene and
RT   identification in four patients of nine different mutations within the
RT   VLCAD gene.";
RL   Hum. Mol. Genet. 5:461-472(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood;
RX   PubMed=8554625; DOI=10.1006/bbrc.1995.2867;
RA   Orii K.O., Aoyama T., Souri M., Orii K.E., Kondo N., Orii T.,
RA   Hashimoto T.;
RT   "Genomic DNA organization of human mitochondrial very-long-chain acyl-
RT   CoA dehydrogenase and mutation analysis.";
RL   Biochem. Biophys. Res. Commun. 217:987-992(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=7769092; DOI=10.1172/JCI117947;
RA   Aoyama T., Souri M., Ushikubo S., Kamijo T., Yamaguchi S.,
RA   Kelley R.I., Rhead W.J., Uetake K., Tanaka K., Hashimoto T.;
RT   "Purification of human very-long-chain acyl-coenzyme A dehydrogenase
RT   and characterization of its deficiency in seven patients.";
RL   J. Clin. Invest. 95:2465-2473(1995).
RN   [8]
RP   REVIEW ON VARIANTS.
RX   PubMed=9973285; DOI=10.1086/302261;
RA   Andresen B.S., Olpin S., Poorthuis B.J.H.M., Scholte H.R.,
RA   Vianey-Saban C., Wanders R., Ijlst L., Morris A., Pourfarzam M.,
RA   Bartlett K., Baumgartner E.R., de Klerk J.B.C., Schroeder L.D.,
RA   Corydon T.J., Lund H., Winter V., Bross P., Bolund L., Gregersen N.;
RT   "Clear correlation of genotype with disease phenotype in very-long-
RT   chain acyl-CoA dehydrogenase deficiency.";
RL   Am. J. Hum. Genet. 64:479-494(1999).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-239 AND LYS-331, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-517 AND SER-522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER TYR-40, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 69-655 IN COMPLEX WITH THE
RP   SUBSTRATE ANALOG MYRISTOYL-COA, FUNCTION, SUBUNIT, COFACTOR, AND
RP   ACTIVE SITE.
RX   PubMed=18227065; DOI=10.1074/jbc.M709135200;
RA   McAndrew R.P., Wang Y., Mohsen A.W., He M., Vockley J., Kim J.J.;
RT   "Structural basis for substrate fatty acyl chain specificity: crystal
RT   structure of human very-long-chain acyl-CoA dehydrogenase.";
RL   J. Biol. Chem. 283:9435-9443(2008).
RN   [15]
RP   VARIANTS ACADVLD GLU-130 DEL; LYS-299 DEL; GLN-382 AND TRP-613.
RX   PubMed=8554073;
RA   Souri M., Aoyama T., Orii K., Yamaguchi S., Hashimoto T.;
RT   "Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase
RT   (VLCAD) deficiency: identification and characterization of mutant
RT   VLCAD cDNAs from four patients.";
RL   Am. J. Hum. Genet. 58:97-106(1996).
RN   [16]
RP   VARIANT ACADVLD HIS-450.
RX   PubMed=9546340; DOI=10.1002/ana.410430422;
RA   Smelt A.H., Poorthuis B.J.H.M., Onkenhout W., Scholte H.R.,
RA   Andresen B.S., van Duinen S.G., Gregersen N., Wintzen A.R.;
RT   "Very long chain acyl-coenzyme A dehydrogenase deficiency with adult
RT   onset.";
RL   Ann. Neurol. 43:540-544(1998).
RN   [17]
RP   VARIANTS ACADVLD.
RX   PubMed=10077518; DOI=10.1161/01.CIR.99.10.1337;
RA   Mathur A., Sims H.F., Gopalakrishnan D., Gibson B., Rinaldo P.,
RA   Vockley J., Hug G., Strauss A.W.;
RT   "Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase
RT   deficiency causing pediatric cardiomyopathy and sudden death.";
RL   Circulation 99:1337-1343(1999).
CC   -!- FUNCTION: Active toward esters of long-chain and very long chain
CC       fatty acids such as palmitoyl-CoA, mysritoyl-CoA and stearoyl-CoA.
CC       Can accommodate substrate acyl chain lengths as long as 24
CC       carbons, but shows little activity for substrates of less than 12
CC       carbons. {ECO:0000269|PubMed:18227065}.
CC   -!- CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + electron-transfer
CC       flavoprotein = a very-long-chain trans-2,3-dehydroacyl-CoA +
CC       reduced electron-transfer flavoprotein.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:18227065};
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-
CC       oxidation.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18227065}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P49748-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49748-2; Sequence=VSP_007734;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P49748-3; Sequence=VSP_046031;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: S-nitrosylation at Cys-237 in liver improves catalytic
CC       efficiency. {ECO:0000250}.
CC   -!- DISEASE: Acyl-CoA dehydrogenase very long-chain deficiency
CC       (ACADVLD) [MIM:201475]: An inborn error of mitochondrial fatty
CC       acid beta-oxidation which leads to impaired long-chain fatty acid
CC       beta-oxidation. It is clinically heterogeneous, with three major
CC       phenotypes: a severe childhood form characterized by early onset,
CC       high mortality and high incidence of cardiomyopathy; a milder
CC       childhood form with later onset, characterized by hypoketotic
CC       hypoglycemia, low mortality and rare cardiomyopathy; an adult
CC       form, with isolated skeletal muscle involvement, rhabdomyolysis
CC       and myoglobinuria, usually triggered by exercise or fasting.
CC       {ECO:0000269|PubMed:10077518, ECO:0000269|PubMed:8554073,
CC       ECO:0000269|PubMed:9546340}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: A number of straight-chain acyl-CoA dehydrogenases
CC       of different substrate specificities are present in mammalian
CC       tissues.
CC   -!- SIMILARITY: Belongs to the acyl-CoA dehydrogenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D43682; BAA07781.1; -; mRNA.
DR   EMBL; L46590; AAA79002.1; -; Genomic_DNA.
DR   EMBL; X86556; CAA60253.1; -; mRNA.
DR   EMBL; D78298; BAA29057.1; -; Genomic_DNA.
DR   EMBL; AK293549; BAG57027.1; -; mRNA.
DR   EMBL; AC120057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000399; AAH00399.1; -; mRNA.
DR   EMBL; BC012912; AAH12912.1; -; mRNA.
DR   EMBL; BC020218; AAH20218.1; -; mRNA.
DR   CCDS; CCDS11090.1; -. [P49748-1]
DR   CCDS; CCDS42249.1; -. [P49748-2]
DR   CCDS; CCDS58509.1; -. [P49748-3]
DR   PIR; S54183; S54183.
DR   RefSeq; NP_000009.1; NM_000018.3. [P49748-1]
DR   RefSeq; NP_001029031.1; NM_001033859.2. [P49748-2]
DR   RefSeq; NP_001257376.1; NM_001270447.1. [P49748-3]
DR   UniGene; Hs.437178; -.
DR   PDB; 2UXW; X-ray; 1.45 A; A=72-655.
DR   PDB; 3B96; X-ray; 1.91 A; A=69-655.
DR   PDBsum; 2UXW; -.
DR   PDBsum; 3B96; -.
DR   ProteinModelPortal; P49748; -.
DR   SMR; P49748; -.
DR   BioGrid; 106555; 38.
DR   IntAct; P49748; 17.
DR   MINT; MINT-4824254; -.
DR   STRING; 9606.ENSP00000349297; -.
DR   SwissLipids; SLP:000001330; -. [P49748-2]
DR   SwissLipids; SLP:000001332; -.
DR   iPTMnet; P49748; -.
DR   PhosphoSitePlus; P49748; -.
DR   SwissPalm; P49748; -.
DR   BioMuta; ACADVL; -.
DR   DMDM; 1703068; -.
DR   EPD; P49748; -.
DR   MaxQB; P49748; -.
DR   PaxDb; P49748; -.
DR   PeptideAtlas; P49748; -.
DR   PRIDE; P49748; -.
DR   Ensembl; ENST00000350303; ENSP00000344152; ENSG00000072778. [P49748-2]
DR   Ensembl; ENST00000356839; ENSP00000349297; ENSG00000072778. [P49748-1]
DR   Ensembl; ENST00000543245; ENSP00000438689; ENSG00000072778. [P49748-3]
DR   GeneID; 37; -.
DR   KEGG; hsa:37; -.
DR   UCSC; uc002gev.5; human. [P49748-1]
DR   CTD; 37; -.
DR   DisGeNET; 37; -.
DR   GeneCards; ACADVL; -.
DR   GeneReviews; ACADVL; -.
DR   HGNC; HGNC:92; ACADVL.
DR   HPA; HPA019006; -.
DR   HPA; HPA020595; -.
DR   MalaCards; ACADVL; -.
DR   MIM; 201475; phenotype.
DR   MIM; 609575; gene.
DR   neXtProt; NX_P49748; -.
DR   OpenTargets; ENSG00000072778; -.
DR   Orphanet; 26793; Very long chain acyl-CoA dehydrogenase deficiency.
DR   PharmGKB; PA24428; -.
DR   eggNOG; KOG0137; Eukaryota.
DR   eggNOG; COG1960; LUCA.
DR   GeneTree; ENSGT00760000119007; -.
DR   HOGENOM; HOG000131665; -.
DR   HOVERGEN; HBG050448; -.
DR   InParanoid; P49748; -.
DR   KO; K09479; -.
DR   OMA; TNRTQFG; -.
DR   OrthoDB; EOG091G04BS; -.
DR   PhylomeDB; P49748; -.
DR   TreeFam; TF105053; -.
DR   BioCyc; MetaCyc:ENSG00000072778-MONOMER; -.
DR   BRENDA; 1.3.8.8; 2681.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   Reactome; R-HSA-77305; Beta oxidation of palmitoyl-CoA to myristoyl-CoA.
DR   UniPathway; UPA00660; -.
DR   ChiTaRS; ACADVL; human.
DR   EvolutionaryTrace; P49748; -.
DR   GenomeRNAi; 37; -.
DR   PRO; PR:P49748; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000072778; -.
DR   CleanEx; HS_ACADVL; -.
DR   ExpressionAtlas; P49748; baseline and differential.
DR   Genevisible; P49748; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003995; F:acyl-CoA dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0004466; F:long-chain-acyl-CoA dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0015980; P:energy derivation by oxidation of organic compounds; TAS:ProtInc.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0033539; P:fatty acid beta-oxidation using acyl-CoA dehydrogenase; ISS:BHF-UCL.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0046322; P:negative regulation of fatty acid oxidation; ISS:BHF-UCL.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; ISS:BHF-UCL.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0001659; P:temperature homeostasis; ISS:BHF-UCL.
DR   Gene3D; 1.10.540.10; -; 1.
DR   InterPro; IPR006089; Acyl-CoA_DH_CS.
DR   InterPro; IPR006091; Acyl-CoA_Oxase/DH_cen-dom.
DR   InterPro; IPR009075; AcylCo_DH/oxidase_C.
DR   InterPro; IPR013786; AcylCoA_DH/ox_N.
DR   InterPro; IPR009100; AcylCoA_DH/oxidase_NM_dom.
DR   Pfam; PF00441; Acyl-CoA_dh_1; 1.
DR   Pfam; PF02770; Acyl-CoA_dh_M; 1.
DR   Pfam; PF02771; Acyl-CoA_dh_N; 1.
DR   SUPFAM; SSF47203; SSF47203; 1.
DR   SUPFAM; SSF56645; SSF56645; 1.
DR   PROSITE; PS00072; ACYL_COA_DH_1; 1.
DR   PROSITE; PS00073; ACYL_COA_DH_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cardiomyopathy;
KW   Complete proteome; Disease mutation; FAD; Fatty acid metabolism;
KW   Flavoprotein; Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome; S-nitrosylation; Transit peptide.
FT   TRANSIT       1     40       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712}.
FT   CHAIN        41    655       Very long-chain specific acyl-CoA
FT                                dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000000515.
FT   NP_BIND     214    223       FAD.
FT   NP_BIND     249    251       FAD.
FT   NP_BIND     435    439       FAD. {ECO:0000250}.
FT   NP_BIND     464    466       FAD.
FT   REGION       41    482       Catalytic.
FT   REGION      338    341       Substrate binding. {ECO:0000250}.
FT   REGION      462    463       Substrate binding.
FT   REGION      483    516       Membrane-anchoring. {ECO:0000305}.
FT   ACT_SITE    462    462       Proton acceptor.
FT                                {ECO:0000269|PubMed:18227065}.
FT   BINDING     223    223       Substrate; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   BINDING     366    366       FAD. {ECO:0000250}.
FT   BINDING     463    463       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   MOD_RES      51     51       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES      71     71       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES      71     71       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     195    195       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     237    237       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     239    239       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     239    239       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     276    276       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     276    276       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     278    278       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     278    278       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     298    298       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     331    331       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     331    331       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     372    372       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     482    482       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     482    482       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     517    517       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     550    550       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     556    556       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     556    556       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   MOD_RES     639    639       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P50544}.
FT   VAR_SEQ       1     20       MQAARMAASLGRQLLRLGGG -> MLGGLAAAAGTRIMGKE
FT                                IEAEAQRPLRQTWRPGQPPAMTAKTM (in isoform
FT                                3). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046031.
FT   VAR_SEQ      47     68       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007734.
FT   VARIANT      17     17       L -> F (in dbSNP:rs2230179).
FT                                /FTId=VAR_029286.
FT   VARIANT      43     43       G -> D (in dbSNP:rs2230178).
FT                                /FTId=VAR_000330.
FT   VARIANT      65     65       P -> L (in dbSNP:rs28934585).
FT                                /FTId=VAR_048176.
FT   VARIANT     130    130       Missing (in ACADVLD).
FT                                {ECO:0000269|PubMed:8554073}.
FT                                /FTId=VAR_000331.
FT   VARIANT     158    158       T -> N (in ACADVLD).
FT                                /FTId=VAR_000332.
FT   VARIANT     159    159       Q -> R (in ACADVLD; dbSNP:rs746688190).
FT                                /FTId=VAR_000333.
FT   VARIANT     174    174       V -> M (in ACADVLD; dbSNP:rs369560930).
FT                                /FTId=VAR_000334.
FT   VARIANT     185    185       G -> S (in ACADVLD; dbSNP:rs545215807).
FT                                /FTId=VAR_000335.
FT   VARIANT     213    213       A -> P (in ACADVLD; dbSNP:rs140629318).
FT                                /FTId=VAR_010101.
FT   VARIANT     218    218       E -> K (in ACADVLD).
FT                                /FTId=VAR_000336.
FT   VARIANT     243    243       L -> R (in ACADVLD).
FT                                /FTId=VAR_000337.
FT   VARIANT     247    247       K -> E (in ACADVLD).
FT                                /FTId=VAR_010102.
FT   VARIANT     247    247       K -> T (in ACADVLD).
FT                                /FTId=VAR_000338.
FT   VARIANT     260    260       T -> M (in ACADVLD; dbSNP:rs113994168).
FT                                /FTId=VAR_000339.
FT   VARIANT     278    278       Missing (in ACADVLD).
FT                                /FTId=VAR_000340.
FT   VARIANT     281    281       A -> D (in ACADVLD).
FT                                /FTId=VAR_000341.
FT   VARIANT     283    283       V -> A (in ACADVLD; dbSNP:rs113994167).
FT                                /FTId=VAR_000342.
FT   VARIANT     290    290       G -> D (in ACADVLD; dbSNP:rs866464446).
FT                                /FTId=VAR_000343.
FT   VARIANT     294    294       G -> E (in ACADVLD; dbSNP:rs200573371).
FT                                /FTId=VAR_000344.
FT   VARIANT     299    299       K -> N (in ACADVLD; dbSNP:rs774716484).
FT                                /FTId=VAR_000345.
FT   VARIANT     299    299       Missing (in ACADVLD).
FT                                {ECO:0000269|PubMed:8554073}.
FT                                /FTId=VAR_000346.
FT   VARIANT     317    317       V -> A (in ACADVLD; dbSNP:rs398123095).
FT                                /FTId=VAR_000347.
FT   VARIANT     352    352       M -> V (in ACADVLD).
FT                                /FTId=VAR_000348.
FT   VARIANT     359    359       A -> S (in dbSNP:rs1051701).
FT                                /FTId=VAR_011990.
FT   VARIANT     366    366       R -> C (in ACADVLD; dbSNP:rs771874163).
FT                                /FTId=VAR_000349.
FT   VARIANT     366    366       R -> H (in ACADVLD; dbSNP:rs112406105).
FT                                /FTId=VAR_000350.
FT   VARIANT     381    381       Missing (in ACADVLD).
FT                                /FTId=VAR_000351.
FT   VARIANT     382    382       K -> Q (in ACADVLD; dbSNP:rs118204015).
FT                                {ECO:0000269|PubMed:8554073}.
FT                                /FTId=VAR_000352.
FT   VARIANT     405    405       D -> H (in ACADVLD).
FT                                /FTId=VAR_000353.
FT   VARIANT     441    441       G -> D (in ACADVLD; dbSNP:rs2309689).
FT                                /FTId=VAR_000354.
FT   VARIANT     450    450       R -> H (in ACADVLD; dbSNP:rs118204016).
FT                                {ECO:0000269|PubMed:9546340}.
FT                                /FTId=VAR_000355.
FT   VARIANT     453    453       R -> Q (in ACADVLD; dbSNP:rs138058572).
FT                                /FTId=VAR_000356.
FT   VARIANT     454    454       D -> N (in ACADVLD).
FT                                /FTId=VAR_000357.
FT   VARIANT     456    456       R -> H (in ACADVLD; dbSNP:rs794727112).
FT                                /FTId=VAR_000358.
FT   VARIANT     458    458       F -> L (in ACADVLD; dbSNP:rs118204017).
FT                                /FTId=VAR_010103.
FT   VARIANT     459    459       R -> W (in ACADVLD; dbSNP:rs766742117).
FT                                /FTId=VAR_000359.
FT   VARIANT     463    463       G -> E (in ACADVLD; dbSNP:rs200366828).
FT                                /FTId=VAR_000360.
FT   VARIANT     469    469       R -> Q (in ACADVLD; dbSNP:rs398123083).
FT                                /FTId=VAR_000361.
FT   VARIANT     469    469       R -> W (in ACADVLD; dbSNP:rs113994170).
FT                                /FTId=VAR_000362.
FT   VARIANT     490    490       A -> P (in ACADVLD; dbSNP:rs759775666).
FT                                /FTId=VAR_010104.
FT   VARIANT     502    502       L -> P (in ACADVLD).
FT                                /FTId=VAR_000363.
FT   VARIANT     534    534       E -> K (in ACADVLD; dbSNP:rs2230180).
FT                                /FTId=VAR_010105.
FT   VARIANT     602    602       L -> I (in ACADVLD).
FT                                /FTId=VAR_000364.
FT   VARIANT     613    613       R -> W (in ACADVLD; dbSNP:rs118204014).
FT                                {ECO:0000269|PubMed:8554073}.
FT                                /FTId=VAR_000365.
FT   VARIANT     615    615       R -> Q (in ACADVLD; dbSNP:rs148584617).
FT                                /FTId=VAR_010106.
FT   VARIANT     623    623       S -> F (in dbSNP:rs13383).
FT                                /FTId=VAR_011991.
FT   CONFLICT    193    193       G -> C (in Ref. 3; BAA29057).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       K -> E (in Ref. 4; BAG57027).
FT                                {ECO:0000305}.
FT   CONFLICT    541    541       E -> K (in Ref. 4; BAG57027).
FT                                {ECO:0000305}.
FT   HELIX        73     77       {ECO:0000244|PDB:2UXW}.
FT   TURN         78     80       {ECO:0000244|PDB:2UXW}.
FT   TURN         85     87       {ECO:0000244|PDB:2UXW}.
FT   HELIX        96    115       {ECO:0000244|PDB:2UXW}.
FT   HELIX       119    125       {ECO:0000244|PDB:2UXW}.
FT   HELIX       130    138       {ECO:0000244|PDB:2UXW}.
FT   TURN        139    142       {ECO:0000244|PDB:2UXW}.
FT   HELIX       148    150       {ECO:0000244|PDB:2UXW}.
FT   HELIX       157    170       {ECO:0000244|PDB:2UXW}.
FT   HELIX       172    182       {ECO:0000244|PDB:2UXW}.
FT   TURN        183    186       {ECO:0000244|PDB:2UXW}.
FT   HELIX       187    192       {ECO:0000244|PDB:2UXW}.
FT   HELIX       195    206       {ECO:0000244|PDB:2UXW}.
FT   STRAND      212    215       {ECO:0000244|PDB:2UXW}.
FT   STRAND      221    223       {ECO:0000244|PDB:2UXW}.
FT   HELIX       225    227       {ECO:0000244|PDB:2UXW}.
FT   STRAND      231    234       {ECO:0000244|PDB:2UXW}.
FT   STRAND      238    251       {ECO:0000244|PDB:2UXW}.
FT   TURN        252    255       {ECO:0000244|PDB:2UXW}.
FT   STRAND      257    268       {ECO:0000244|PDB:2UXW}.
FT   TURN        270    272       {ECO:0000244|PDB:2UXW}.
FT   STRAND      275    285       {ECO:0000244|PDB:2UXW}.
FT   HELIX       286    288       {ECO:0000244|PDB:2UXW}.
FT   STRAND      289    293       {ECO:0000244|PDB:2UXW}.
FT   STRAND      307    318       {ECO:0000244|PDB:2UXW}.
FT   HELIX       319    321       {ECO:0000244|PDB:2UXW}.
FT   STRAND      322    325       {ECO:0000244|PDB:2UXW}.
FT   HELIX       329    365       {ECO:0000244|PDB:2UXW}.
FT   HELIX       373    375       {ECO:0000244|PDB:2UXW}.
FT   HELIX       377    405       {ECO:0000244|PDB:2UXW}.
FT   HELIX       412    437       {ECO:0000244|PDB:2UXW}.
FT   HELIX       439    442       {ECO:0000244|PDB:2UXW}.
FT   HELIX       448    455       {ECO:0000244|PDB:2UXW}.
FT   HELIX       456    459       {ECO:0000244|PDB:2UXW}.
FT   STRAND      461    463       {ECO:0000244|PDB:2UXW}.
FT   HELIX       465    485       {ECO:0000244|PDB:2UXW}.
FT   HELIX       486    488       {ECO:0000244|PDB:2UXW}.
FT   TURN        522    524       {ECO:0000244|PDB:3B96}.
FT   HELIX       527    529       {ECO:0000244|PDB:2UXW}.
FT   HELIX       530    554       {ECO:0000244|PDB:2UXW}.
FT   HELIX       555    560       {ECO:0000244|PDB:2UXW}.
FT   HELIX       562    591       {ECO:0000244|PDB:2UXW}.
FT   HELIX       596    622       {ECO:0000244|PDB:2UXW}.
FT   HELIX       627    644       {ECO:0000244|PDB:2UXW}.
SQ   SEQUENCE   655 AA;  70390 MW;  A5594D1EA7911D19 CRC64;
     MQAARMAASL GRQLLRLGGG SSRLTALLGQ PRPGPARRPY AGGAAQLALD KSDSHPSDAL
     TRKKPAKAES KSFAVGMFKG QLTTDQVFPY PSVLNEEQTQ FLKELVEPVS RFFEEVNDPA
     KNDALEMVEE TTWQGLKELG AFGLQVPSEL GGVGLCNTQY ARLVEIVGMH DLGVGITLGA
     HQSIGFKGIL LFGTKAQKEK YLPKLASGET VAAFCLTEPS SGSDAASIRT SAVPSPCGKY
     YTLNGSKLWI SNGGLADIFT VFAKTPVTDP ATGAVKEKIT AFVVERGFGG ITHGPPEKKM
     GIKASNTAEV FFDGVRVPSE NVLGEVGSGF KVAMHILNNG RFGMAAALAG TMRGIIAKAV
     DHATNRTQFG EKIHNFGLIQ EKLARMVMLQ YVTESMAYMV SANMDQGATD FQIEAAISKI
     FGSEAAWKVT DECIQIMGGM GFMKEPGVER VLRDLRIFRI FEGTNDILRL FVALQGCMDK
     GKELSGLGSA LKNPFGNAGL LLGEAGKQLR RRAGLGSGLS LSGLVHPELS RSGELAVRAL
     EQFATVVEAK LIKHKKGIVN EQFLLQRLAD GAIDLYAMVV VLSRASRSLS EGHPTAQHEK
     MLCDTWCIEA AARIREGMAA LQSDPWQQEL YRNFKSISKA LVERGGVVTS NPLGF
//
